Gerresheimer (ETR:GXI) has been given a €77.00 ($95.06) price target by Commerzbank in a report released on Monday. The brokerage presently has a “buy” rating on the stock. Commerzbank’s price objective indicates a potential upside of 13.24% from the company’s current price.
A number of other analysts have also issued reports on the stock. Berenberg Bank set a €75.00 ($92.59) price target on shares of Gerresheimer and gave the stock a “buy” rating in a research note on Friday, December 8th. Deutsche Bank set a €64.00 ($79.01) price target on shares of Gerresheimer and gave the stock a “neutral” rating in a research note on Thursday, October 12th. Hauck & Aufhaeuser set a €55.00 ($67.90) price target on shares of Gerresheimer and gave the stock a “sell” rating in a research note on Wednesday, January 10th. Credit Suisse Group set a €80.00 ($98.77) price target on shares of Gerresheimer and gave the stock a “buy” rating in a research note on Tuesday, October 10th. Finally, Goldman Sachs Group set a €69.50 ($85.80) price target on shares of Gerresheimer and gave the stock a “neutral” rating in a research note on Thursday, October 12th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of €71.61 ($88.41).
Shares of Gerresheimer (ETR:GXI) opened at €68.00 ($83.95) on Monday. The stock has a market cap of $2,170.00 and a PE ratio of 48.23. Gerresheimer has a one year low of €59.97 ($74.04) and a one year high of €78.25 ($96.60).
ILLEGAL ACTIVITY WARNING: “Gerresheimer (GXI) Given a €77.00 Price Target at Commerzbank” was first posted by Stock Observer and is the property of of Stock Observer. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://www.thestockobserver.com/2018/02/05/gerresheimer-gxi-given-a-77-00-price-target-at-commerzbank.html.
Gerresheimer Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.